2.17
price down icon0.46%   -0.01
 
loading
Precedente Chiudi:
$2.18
Aprire:
$2.15
Volume 24 ore:
497.73K
Relative Volume:
0.57
Capitalizzazione di mercato:
$245.60M
Reddito:
$45.44M
Utile/perdita netta:
$-35.43M
Rapporto P/E:
-6.3824
EPS:
-0.34
Flusso di cassa netto:
$-25.39M
1 W Prestazione:
-2.03%
1M Prestazione:
-8.82%
6M Prestazione:
-47.84%
1 anno Prestazione:
-43.34%
Intervallo 1D:
Value
$2.1335
$2.25
Intervallo di 1 settimana:
Value
$2.00
$2.316
Portata 52W:
Value
$2.00
$5.20

Maxcyte Inc Stock (MXCT) Company Profile

Name
Nome
Maxcyte Inc
Name
Telefono
301-517-5556
Name
Indirizzo
9713 KEY WEST AVENUE,, ROCKVILLE
Name
Dipendente
114
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-11
Name
Ultimi documenti SEC
Name
MXCT's Discussions on Twitter

Confronta MXCT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Medical Devices icon
MXCT
Maxcyte Inc
2.17 245.60M 45.44M -35.43M -25.39M -0.34
Medical Devices icon
ABT
Abbott Laboratories
136.26 233.36B 42.34B 13.50B 6.66B 7.71
Medical Devices icon
BSX
Boston Scientific Corp
104.78 147.06B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
396.74 145.64B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
88.75 112.76B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
77.18 44.46B 5.54B 4.18B 623.10M 7.00

Maxcyte Inc Stock (MXCT) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2023-11-29 Iniziato Craig Hallum Buy
2021-10-15 Ripresa Cowen Outperform
2021-08-24 Iniziato BTIG Research Buy
2021-08-24 Iniziato Cowen Outperform
2021-08-24 Iniziato Stephens Overweight
2021-08-24 Iniziato Stifel Buy
2021-08-24 Iniziato Wedbush Outperform
2021-08-24 Iniziato William Blair Outperform
Mostra tutto

Maxcyte Inc Borsa (MXCT) Ultime notizie

pulisher
Jun 18, 2025

MaxCyte Shareholders Approve Equity Plan Amendment - TipRanks

Jun 18, 2025
pulisher
Jun 18, 2025

MaxCyte shareholders approve equity plan expansion, AIM delisting - Investing.com

Jun 18, 2025
pulisher
Jun 18, 2025

Analyzing Ratios: MaxCyte Inc (MXCT)’s Financial Story Unveiled - DWinneX

Jun 18, 2025
pulisher
Jun 13, 2025

California State Teachers Retirement System Sells 82,134 Shares of MaxCyte, Inc. (NASDAQ:MXCT) - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

MaxCyte Announces Change in Major Holdings by BlackRock - TipRanks

Jun 12, 2025
pulisher
Jun 11, 2025

MaxCyte and Ori Biotech partner to enhance cell therapy manufacturing By Investing.com - Investing.com South Africa

Jun 11, 2025
pulisher
Jun 11, 2025

MaxCyte & Ori Biotech Integrate Platforms for Efficient Manufacturing - Contract Pharma

Jun 11, 2025
pulisher
Jun 11, 2025

Market news - investments.halifax.co.uk

Jun 11, 2025
pulisher
Jun 11, 2025

MaxCyte enters collaboration with Ori Biotech - Sharecast.com

Jun 11, 2025
pulisher
Jun 11, 2025

MaxCyte (MXCT) Partners with Ori Biotech to Boost Cell Therapy Manufacturing | MXCT Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

MaxCyte and Ori Biotech partner to enhance cell therapy manufacturing - Investing.com Australia

Jun 11, 2025
pulisher
Jun 11, 2025

MaxCyte and Ori Biotech Collaborate to Improve Manufacturing Efficiencies and Broaden Adoption of Autologous Cellular Therapies - The Manila Times

Jun 11, 2025
pulisher
Jun 11, 2025

MaxCyte and Ori Biotech Forge Strategic Partnership to Enhance Cell Therapy Manufacturing Efficiency - Nasdaq

Jun 11, 2025
pulisher
Jun 11, 2025

MaxCyte and Ori Biotech Join Forces to Transform CAR-T Cell Production Timeline and Efficiency - Stock Titan

Jun 11, 2025
pulisher
Jun 10, 2025

MaxCyte and Ori Biotech Collaborate to Enhance Cell Therapy Manufacturing - TipRanks

Jun 10, 2025
pulisher
Jun 09, 2025

Kalkine: NASDAQ Today Sees Movement in MaxCyte Amid Sector-Wide Shifts - Kalkine Media

Jun 09, 2025
pulisher
Jun 09, 2025

Squarepoint Ops LLC Decreases Position in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World

Jun 09, 2025
pulisher
Jun 09, 2025

Two Sigma Advisers LP Purchases Shares of 17,800 MaxCyte, Inc. (NASDAQ:MXCT) - Defense World

Jun 09, 2025
pulisher
Jun 08, 2025

MaxCyte (NASDAQ:MXCT) Rating Increased to Hold at Wall Street Zen - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

MaxCyte Announces Change in Voting Rights Structure - TipRanks

Jun 06, 2025
pulisher
Jun 05, 2025

BlackRock Increases Stake in MaxCyte to 9.98% - TipRanks

Jun 05, 2025
pulisher
Jun 05, 2025

Nuveen Asset Management LLC Cuts Stake in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World

Jun 05, 2025
pulisher
Jun 03, 2025

ProShare Advisors LLC Has $143,000 Stake in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

BNP Paribas Financial Markets Takes $56,000 Position in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

BlackRock Increases Stake in MaxCyte - TipRanks

Jun 02, 2025
pulisher
Jun 02, 2025

MaxCyte Expands Stock Capital Amidst Strategic Growth - TipRanks

Jun 02, 2025
pulisher
Jun 02, 2025

Jane Street Group LLC Purchases 12,209 Shares of MaxCyte, Inc. (NASDAQ:MXCT) - Defense World

Jun 02, 2025
pulisher
May 31, 2025

MaxCyte (NASDAQ:MXCT) Downgraded to “Sell” Rating by Wall Street Zen - Defense World

May 31, 2025
pulisher
May 31, 2025

Deutsche Bank AG Buys 38,782 Shares of MaxCyte, Inc. (NASDAQ:MXCT) - Defense World

May 31, 2025
pulisher
May 27, 2025

D. E. Shaw & Co. Inc. Buys 84,105 Shares of MaxCyte, Inc. (NASDAQ:MXCT) - Defense World

May 27, 2025
pulisher
May 23, 2025

MaxCyte Announces Change in Major Shareholder Voting Rights - TipRanks

May 23, 2025
pulisher
May 23, 2025

BlackRock Increases Stake in MaxCyte, Boosting Voting Rights - TipRanks

May 23, 2025
pulisher
May 19, 2025

BlackRock Increases Stake in MaxCyte to 7.65% - TipRanks

May 19, 2025
pulisher
May 18, 2025

Price T Rowe Associates Inc. MD Has $177,000 Position in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World

May 18, 2025
pulisher
May 16, 2025

MaxCyte Announces Change in Major Shareholder Holdings - TipRanks

May 16, 2025
pulisher
May 16, 2025

MaxCyte, Inc. (MXCT): A Bull Case Theory - MSN

May 16, 2025
pulisher
May 15, 2025

MaxCyte Inc (MXCT): Be Patient, You Will Learn - Stocksregister

May 15, 2025
pulisher
May 13, 2025

MaxCyte, Inc. (NASDAQ:MXCT) Q1 2025 Earnings Call Transcript - Insider Monkey

May 13, 2025
pulisher
May 12, 2025

MaxCyte’s Earnings Call: Navigating Challenges and Opportunities - TipRanks

May 12, 2025
pulisher
May 12, 2025

William Blair Predicts MaxCyte’s Q2 Earnings (NASDAQ:MXCT) - Defense World

May 12, 2025
pulisher
May 11, 2025

Hsbc Holdings PLC Purchases 16,554 Shares of MaxCyte, Inc. (NASDAQ:MXCT) - Defense World

May 11, 2025
pulisher
May 09, 2025

MaxCyte Files Form 10-Q for Q1 2025 - TipRanks

May 09, 2025
pulisher
May 09, 2025

BTIG cuts MaxCyte stock price target to $5, maintains Buy rating - Investing.com

May 09, 2025
pulisher
May 09, 2025

MaxCyte, Inc. (MXCT) Reports Q1 Loss, Tops Revenue Estimates - MSN

May 09, 2025
pulisher
May 09, 2025

MaxCyte (MXCT) Upgraded to Buy: Here's What You Should Know - MSN

May 09, 2025
pulisher
May 08, 2025

Earnings call transcript: MaxCyte Q1 2025 beats revenue forecast, stock reacts - Investing.com

May 08, 2025
pulisher
May 08, 2025

Wells Fargo & Company MN Boosts Holdings in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World

May 08, 2025
pulisher
May 08, 2025

MaxCyte Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Guidance - The Manila Times

May 08, 2025
pulisher
May 08, 2025

MaxCyte Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 08, 2025

Maxcyte Inc Azioni (MXCT) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Maxcyte Inc Azioni (MXCT) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Soleymannezhad Ali
Chief Commercial Officer
Mar 18 '25
Sale
3.18
1,211
3,850
59,439
Sandoval David I.
GENERAL COUNSEL
Mar 18 '25
Sale
3.18
353
1,122
64,219
Swirsky Douglas J
CHIEF FINANCIAL OFFICER
Mar 18 '25
Sale
3.18
6,939
22,061
111,811
Johnston John Joseph
Director
Jan 27 '25
Option Exercise
2.93
3,000
8,796
144,950
Johnston John Joseph
Director
Jan 27 '25
Sale
4.64
3,000
13,935
141,950
Sandoval David I.
GENERAL COUNSEL
Jan 13 '25
Sale
4.54
4,466
20,272
41,447
Johnston John Joseph
Director
Dec 26 '24
Option Exercise
2.93
3,000
8,796
144,950
Johnston John Joseph
Director
Dec 26 '24
Sale
4.01
3,000
12,021
141,950
$299.99
price down icon 4.52%
medical_devices PHG
$24.20
price up icon 0.92%
medical_devices STE
$242.66
price up icon 1.02%
$83.58
price down icon 4.25%
$75.95
price up icon 2.54%
medical_devices EW
$77.18
price down icon 1.32%
Capitalizzazione:     |  Volume (24 ore):